Company Founder Takes the Helm of etectRx, a Digital Health Company GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of Eric Buffkin as its next...
Read morePress Releases
etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users
GAINESVILLE, Fla. & BOSTON, Mass. (May 4, 2021) – Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy adherence among prescription opioid users living with HIV. The study, dubbed...
Read moreetectRx Targets Mental Health Field In Partnership With Local Health Pharmacy
GAINESVILLE, Fla. (February 26, 2021) – Digital health company, etectRx, Inc., announced a signed letter of intent for a novel partnership with Local Health, Inc., a subsidiary of OneroRx, a leader in operating telepharmacies and community retail...
Read moreDigital Pill Company etectRx Selects Biotech Leader as VP of Product Management
GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role, Standley’s main responsibility is setting the direction for the etectRx...
Read moreetectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics
GAINESVILLE, Fla. (January 14, 2021) – Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space...
Read moreetectRx Strengthens Intellectual Property Portfolio with 15th Issued Patent Supporting Digital Pill Innovation
GAINESVILLE, Fla. (October 7, 2020) – etectRx, Inc. recently announced that the United States Patent and Trademark Office has issued U.S. Patent 10,765,360 for an “Electronic medication compliance monitoring system and associated methods.” The...
Read moreetectRx™ Announces Clinical Study Aimed at Improving Medication Adherence
ID-Cap™ System Will Allow Clinicians to Remotely Track Ingestion Events and Provide Feedback to Patients GAINESVILLE, Fla. (September 10, 2020) – Digital health company etectRx™, Inc. (etectRx™), today announced that its...
Read moreetectRx™ Announces New CEO
Pharma Executive Brought in to Drive Digital Pill Use Cases GAINESVILLE, Fla. (August 20, 2020) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of pharma veteran Valerie...
Read moreBreakthrough ID-Cap System from etectRx™ Selected to Measure Adherence to HIV Treatment in New University of Colorado Study
Announcement coincides with the issuance of two new U.S. Patents GAINESVILLE, Fla. (January 12, 2020) – etectRx™, Inc. (etectRx™), a privately-held digital health company, today announced the ID-Cap™ System is being utilized...
Read moreetectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker
ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Fla. (December 9, 2019) – etectRx®, Inc. (etectRx), a privately-held digital health company, today announced U.S. Food and Drug Administration (FDA)...
Read moreetectRx, Inc. Announces Issuance of Additional U.S. Patents for Ingestible Medication Adherence System
GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance...
Read moreetectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities
Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to further develop the manufacturing and...
Read more